Areas of Interest at Shionogi & Co.
Shionogi & Co., Ltd. business development
Shionogi & Co., Ltd. conducts its research and development program based on its policy of continually providing the superior medicines essential to people´s health. This commitment has allowed them to continually develop innovative medicines with excellent safety and efficacy profiles and to deliver high-quality products to many people suffering from illness.
They will spare no effort in carrying out challenging and speedy research and development to fulfill their mission of delivering pharmaceuticals that offer an even higher level of satisfaction to patients` their families and healthcare providers and improve the quality of life for patients and their families.
In addition to the three targeted areas of infections` pain and metabolic syndrome` Shionogi is also focusing on disease areas such as allergies` respiratory illnesses` cancer and central nervous system disorders that will add challenging frontier research for future advances. With this approach` Shionogi will maintain a steadily flowing product pipeline centered on internally developed products` and plans to move at least five new items to Phase âÂÂ ¡ or higher by the end of the second medium-term management plan in March 2010.
Shionogi´s research laboratories aggressively apply cutting-edge scientific technologies such as ultra-high-throughput screening and genomic drug discovery to facilitate the efficient development of innovative pharmaceuticals.
In addition` Shionogi actively collaborates with external research institutions to strengthen basic technologies for drug discovery and drug discovery target searches.